Effect of Music Therapy on Patients Undergoing Intravitreal Injections

Sponsor
Yale University (Other)
Overall Status
Completed
CT.gov ID
NCT00702039
Collaborator
(none)
50
1
51.9
1

Study Details

Study Description

Brief Summary

Multiple studies in various specialties, including ophthalmology, are reported in the literature that show that playing music during a procedure (dubbed music therapy) increases patient satisfaction and may reduce patient anxiety and stress levels.

There is no study in the literature that assesses the effects of listening to music in patients undergoing intravitreal injections. This study aims to assess whether listening to music improves patient satisfaction or reduces their anxiety levels in subjects undergoing intravitreal injections.

Condition or Disease Intervention/Treatment Phase
  • Other: No Music
  • Other: Music Therapy

Study Design

Study Type:
Observational
Actual Enrollment :
50 participants
Observational Model:
Case-Control
Time Perspective:
Prospective
Official Title:
Effect of Music Therapy on Patients Undergoing Intravitreal Injections
Study Start Date :
Feb 1, 2007
Actual Primary Completion Date :
Feb 1, 2009
Actual Study Completion Date :
Jun 1, 2011

Arms and Interventions

Arm Intervention/Treatment
1

Those patients receiving intravitreal injections who will be listening to classical music during injection.

Other: Music Therapy
Classical music being played during intravitreal injection.

2

Those patients receiving intravitreal injections who will not be listening to any music during injection.

Other: No Music
No music will be played in patients in arm 2 of the study.

Outcome Measures

Primary Outcome Measures

  1. This study aims to assess what affects music therapy has on patients receiving intravitreal injections. The subject will take a Satisfaction Survey after the procedure and an Anxiety Survey before and after the injection. [Before and after the subject's intravitreal injection.]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Those patients at least 18 years old already scheduled for intravitreal injections.
Exclusion Criteria:
  • Those patients not interested in participating in the study or not capable of filling out the questionnaire secondary to limited mental capability.

  • Non- English speaking subjects will be excluded from the study.

  • Those patients that participated in the study will not be allowed to participate a second time.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Yale Eye Center New Haven Connecticut United States 06510

Sponsors and Collaborators

  • Yale University

Investigators

  • Principal Investigator: Ron Adelman, MD, Yale University Department of Ophthalmology

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Yale University
ClinicalTrials.gov Identifier:
NCT00702039
Other Study ID Numbers:
  • 0702002303
First Posted:
Jun 19, 2008
Last Update Posted:
Jan 17, 2018
Last Verified:
Jan 1, 2018

Study Results

No Results Posted as of Jan 17, 2018